ACS Nano 2015-01-01

In vivo compatibility of graphene oxide with differing oxidation states.

Stefanie A Sydlik, Siddharth Jhunjhunwala, Matthew J Webber, Daniel G Anderson, Robert Langer

Index: ACS Nano 9 , 3866-74, (2015)

Full Text: HTML

Abstract

Graphene oxide (GO) is suggested to have great potential as a component of biomedical devices. Although this nanomaterial has been demonstrated to be cytocompatible in vitro, its compatibility in vivo in tissue sites relevant for biomedical device application is yet to be fully understood. Here, we evaluate the compatibility of GO with two different oxidation levels following implantation in subcutaneous and intraperitoneal tissue sites, which are of broad relevance for application to medical devices. We demonstrate GO to be moderately compatible in vivo in both tissue sites, with the inflammatory reaction in response to implantation consistent with a typical foreign body reaction. A reduction in the degree of GO oxidation results in faster immune cell infiltration, uptake, and clearance following both subcutaneous and peritoneal implantation. Future work toward surface modification or coating strategies could be useful to reduce the inflammatory response and improve compatibility of GO as a component of medical devices.


Related Compounds

Related Articles:

Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.

2015-01-03

[Vaccine 33(2) , 346-53, (2014)]

Comparison of mcl-Poly(3-hydroxyalkanoates) synthesis by different Pseudomonas putida strains from crude glycerol: citrate accumulates at high titer under PHA-producing conditions.

2014-01-01

[BMC Biotechnol. 14 , 962, (2015)]

Process development for scum to biodiesel conversion.

2015-06-01

[Bioresour. Technol. 185 , 185-93, (2015)]

Lipid production in the under-characterized oleaginous yeasts, Rhodosporidium babjevae and Rhodosporidium diobovatum, from biodiesel-derived waste glycerol.

2015-06-01

[Bioresour. Technol. 185 , 49-55, (2015)]

Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.

2014-12-01

[Growth Factors 32(6) , 236-46, (2014)]

More Articles...